RecruitingOverweightObesityOverweight and/or Obesity
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
Eligible age
18+ yrs
Accepts
All genders
Locations
20 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).
Sponsor: Pfizer
You may qualify if…
- ✓ Eligible participants for this study include:
- ✓ adults aged 18 years or older with
- ✓ obesity (BMI of 30.0 kg/m2 to 50.0 kg/m2) or with
- ✓ overweight (BMI of 27.0 kg/m2 to \<30.0 kg/m2) who also have at least 1 prespecified weight-related comorbidity (hypertension, dyslipidemia, cardiovascular disease, or obstructive sleep apnea), at the screening visit.
You may not qualify if…
- ✕ Participants who are not eligible include those with diabetes mellitus, a body weight change of \>5% or use of weight loss medications in the 12 weeks prior to screening, a history of or plan for surgical treatment for obesity, and those who are unable or unwilling to comply with contraceptive requirements or are pregnant or lactating.
Where it's recruiting
Arizona
Chandler · Sun City West · Tucson
California
Fountain Valley · Garden Grove · Long Beach · Los Alamitos …
Florida
Hialeah · Jacksonville · Miami · Orlando
Georgia
Atlanta · Stockbridge
Illinois
Morton · Naperville
Kansas
Lenexa
Louisiana
Mandeville · Prairieville
Maryland
Lutherville
Missouri
Springfield
Montana
Butte
Nevada
Las Vegas
New Jersey
Hamilton
Source: ClinicalTrials.gov · NCT07575932 · last updated 2026-06-10